An Idaho Senate committee killed a bill that would implement Medicaid work requirements in the state; the FDA is proposing requiring that women receive information on their breast density after a mammogram; and President Trump will reportedly submit a healthcare plan to Congress this year.
Following news that a federal judge tossed out Medicaid work requirements in Kentucky and Arkansas, an Idaho Senate committee voted 7-2 against a House bill that would have implemented work requirements in the state, reported the Idaho Statesman. The bill would have put guardrails on the voter-approved Medicaid expansion. Similar to other work requirement bills, parents, caregivers, people with disabilities, and college students would have been exempt.The FDA has proposed a rule that would require women be informed of their breast density, which can sometimes make cancer harder to detect when getting a mammogram. According to the Associated Press, If implemented, women would receive a short summary about their breast density, and those with dense breasts would get a letter notifying them that their tissue makes it harder to find cancer and could require more testing. They would also receive a recommendation to speak with a doctor.According to a former White House aide, President Trump is planning on submitting a healthcare plan to Congress this year. The announcement comes after the Department of Justice sided with a federal judge who ruled that the entire Affordable Care Act (ACA) should be invalidated. Following the decision, Trump called the ACA a “disaster,” saying that premiums are too high and that the Republican party would be “the party of great healthcare,” reported The Hill.
Quadrivalent Influenza Vaccines Provide Higher Immunogenicity Against B Lineage vs Trivalent
December 5th 2023Overall, the study authors concluded that the immunogenicity of quadrivalent influenza vaccines (QIV) and trivalent inactivated influenza vaccines (TIV) was similar for common influenza ingredients for children ages 6 to 35 months.
Read More
Clinical Characteristics, Outcomes of Patients With Plaque Psoriasis on Tapinarof Cream
December 5th 2023Two posters presented at the 2023 Fall Clinical Dermatology Conference examined patient demographics, clinical characteristics, and outcomes in patients with plaque psoriasis treated with tapinerof cream.
Read More